Authors

Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.

Karishma Daftary, BA

Latest Article

Think Globally to Combat Acne

Take a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.

Lauren Joszt

Latest Article

Atopic Dermatitis Remains Controlled Even After Reduction of Dupilumab Dose

Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences

Patients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.

Latest Article

Saving the World Through Pharmaceutical Innovation

6 years ago

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.

Doris Day, MD, FAAD

Latest Article

The Cutaneous Connection: Skin Changes, Hormones, and the Menopause Conversation in Aesthetics

8 months ago

In the latest Cutaneous Connection podcast episode, Doris Day, MD, FAAD, offers practical guidance for clinicians looking to incorporate discussions of hormonal health into aesthetic consultations with menopausal patients.

Jason M. O'Dell, MS, CWM

Latest Article

Offering an Insurance Package to Retain and Reward Employees: What Dermatologists Should Know

Explore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.

Michael Heile, MD, FAAFP

Paul Scott Premo

Latest Article

CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and Aging

David M. Pariser, MD, FACP, FAAD

Take a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.

Latest Article

Improving Hyperhidrosis Treatment: The Role of IHhS

Louise Gagnon; Reviewed by Dr Rachel Curtis

David M. Pariser, MD, FACP, FAAD, secretary and a founding board member of the International Hyperhidrosis Society, discussed the latest in hyperhidrosis research and the organization’s commitment to helping clinicians treat the condition.

Nicole Canfora Lupo

Latest Article

Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials

a month ago

Dermatitis-related adverse events vary widely across atopic dermatitis systemic trials, driven by disease fluctuation and reporting differences, informing patient counseling and flare definitions.

Regeneron and Sanofi

Jamie L. York

Brian Biesman, MD, FACS

Latest Article

Outlining SCALE 2023 with Brian Biesman, MD, FACS

As co-director, Biesman is looking forward to all attendees being able to find medical and aesthetic sessions relevant to their education.

Meletios A. Dimopoulos

Laura Rezac, MD

Latest Article

Creating a Telehealth Experience For Postoperative Appointments

Laura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.

Jim Lee, MD, PhD

Latest Article

Jim Lee, MD, PhD, Reflects on New Research at AAD and Advances in Dermatology

"It's an exciting time" in dermatology, said Lee, who reflects on late-breaker data and other research presented at the 2024 AAD Annual Meeting.

Skylar Jeremias

Latest Article

ICYMI: FDA Greenlights Yesintek, Sixth Biosimilar to Stelara, for Psoriasis and Psoriatic Arthritis

The FDA recently approved Yesintek for treating psoriasis, psoriatic arthritis, and IBD, with a 2025 launch expected.

Steven A. Davis, M.D.

Latest Article

My experience with surface radiotherapy

6 years ago

Superficial radiation offers a newer, FDA-approved office-based option that is safe. Steven A. Davis, M.D., shares his experience using surface radiotherapy to treat his patients with non-melanoma skin cancer.

Maggi Ahmed, MD, PhD

Latest Article

Combining Surgical Precision With Immunological Innovation in Vitiligo Treatment

Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.

Michael Somenek, MD

Latest Article

Advancing Aesthetics: Innovations, Trends, and Patient-Centric Strategies in the Era of Weight Loss Medications

Elizabeth Berry, MD, FAAD

Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.

Kate Goldie, MBChB

Latest Article

Skin Quality: Defined by Global Consensus, Delivered Through Personalized Treatment

a year ago

Aesthetic medicine embraces a holistic approach to skin quality, defining it through measurable categories that enhance personalized treatment strategies.

Scotty Sykes, CPA, CFP

Elizabeth Berry, MD, FAAD, is an associate professor of dermatology and the director of the Multidisciplinary Melanoma Clinic and the Pigmented Lesions Clinic at Oregon Health and Science University.

Latest Article

Mastering Dermoscopy and Dysplastic Nevi

Elizabeth Berry, MD, FAAD, reviewed dysplastic nevi as risk markers and highlighted the need for more data on severe cases at AAD 2025.

Viviane Liao

Latest Article

Overview of Prurigo Nodularis for Practicing Dermatology Clinicians

It is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.

Kristie L. Kahl

Latest Article

Neoadjuvant Cemiplimab Induces Promising Pathologic Complete Response in CSCC

Neoadjuvant treatment with cemiplimab led to near or complete disappearance of cutaneous squamous cell carcinoma in almost 64% of patients set to undergo surgery.

Cole Villaflor

Latest Article

Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician Perspectives

Maral Kibarian Skelsey, MD

Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.

Latest Article

Maral Kibarian Skelsey, MD, Shares Insights Into DermTech’s 2-GEP Assay Success

DermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.

Suzan Obagi, M.D.

Rylan DeStefano

Latest Article

Anti-Cancer Immunotherapy Treatments Spark Common Skin-Related Toxicities